share_log

ImmunoPrecise Antibodies | SC 13D: Statement of acquisition of beneficial ownership by individuals-Ingalls & Snyder, LLC(4.22%)

SEC announcement ·  Jul 7, 2023 15:22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more